October 1, 2025
Antibody-drug conjugate (ADC) resistance represents one of the most formidable challenges in precision oncology, with clinical failures often attributed to our limited understanding of the dynamic molecular mechanisms underlying therapeutic escape. Panome Bio’s advanced phosphoproteomics research services provide unprecedented insight into resistance-associated signaling networks, enabling researchers to dissect the complex phosphorylation cascades that drive ADC […]
September 13, 2025
Your ELISA confirms the therapeutic enzyme is present. Your Western blot shows a band at the correct molecular weight. But here’s the critical question: is the enzyme actually functional? For mRNA-based enzyme replacement therapies targeting rare metabolic diseases, producing protein mass isn’t enough. Many enzymes require specific phosphorylation patterns for catalytic activity. Without direct measurement […]
April 16, 2025
This sample data report characterizes global changes in protein phosphorylation, protein expression, and pathway activity due to reduced KRAS activity. Gain a better understanding of phosphorylation events with Panome Bio’s global phosphoproteomics service offering.
